Innovator U.S. Equity Ultra Buffer ETF - March (UMAR) seeks to provide exposure to the SPDR S&P 500 ETF Trust while offering downside protection through a defined outcome strategy. This buffer ETF uses options to limit losses to approximately 15% over a one-year period ending each March, while capping upside gains at a predetermined level.
How It Works
UMAR employs a sophisticated options overlay strategy that purchases protective put options and sells call options on the S&P 500. The fund resets annually each March, establishing new buffer and cap levels based on prevailing option prices. Rather than holding individual stocks, it primarily invests in FLEX options (flexible exchange-traded options) that are customized to achieve the specific 15% downside buffer and upside cap. The strategy is passively managed but mechanically complex, requiring precise options positioning.
Key Features
- Provides 15% downside buffer protection over 12-month periods, limiting losses even if S&P 500 declines significantly
- Annual reset each March allows investors to lock in new buffer and cap levels based on current market conditions
- Uses FLEX options for precise customization rather than standard listed options, enabling exact buffer and cap implementation
Risks
- This ETF can lose value beyond the 15% buffer if S&P 500 declines more than the protected amount in the outcome period
- Upside gains are capped at predetermined levels, potentially missing significant market rallies that exceed the annual cap rate
- Options complexity and annual reset mechanism may create tracking differences and periods of underperformance versus direct S&P 500 exposure
Who Should Own This
Best suited for conservative investors with 1-year holding periods who want equity exposure with defined downside protection. Medium risk tolerance required as losses up to 15% are still possible. Works as a satellite holding (10-25% allocation) for investors seeking to reduce portfolio volatility while maintaining some equity upside participation during the March-to-March outcome periods.